Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer-Reference-Cited by-同舟云学术

Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer

Published:2002-06 Issue:3 Volume:85 Page:517-523
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hofstra L.S.,Bos A.M.E.,de Vries E.G.E.,van der Zee A.G.J.,Willemsen A.T.M.,Rosing H.,Beijnen J.H.,Mulder N.H.,Aalders J.G.,Willemse P.H.B.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference34 articles.

1. Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality;Yancik;Cancer,1993

2. Cancer of the ovary;Cannistra;N Engl J Med,1993

3. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration;Hainsworth;Ann Intern Med,1988

4. Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma;Neijt;J Clin Oncol,1987

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects;Journal of Oncology Pharmacy Practice;2024-01-10

2. Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies;Drugs;2023-01-12

3. A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity;Cancer Chemotherapy and Pharmacology;2019-01-08

4. Intraperitoneal Chemotherapy: Historic Anomaly or Hope for the Future?;Clinical Oncology;2018-08

5. A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies;Cancer Chemotherapy and Pharmacology;2015-04-23